452 related articles for article (PubMed ID: 15001781)
1. A toll-like receptor that prevents infection by uropathogenic bacteria.
Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
[TBL] [Abstract][Full Text] [Related]
2. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.
Säemann MD; Weichhart T; Zeyda M; Staffler G; Schunn M; Stuhlmeier KM; Sobanov Y; Stulnig TM; Akira S; von Gabain A; von Ahsen U; Hörl WH; Zlabinger GJ
J Clin Invest; 2005 Feb; 115(2):468-75. PubMed ID: 15650774
[TBL] [Abstract][Full Text] [Related]
3. Immunology. After the toll rush.
O'Neill LA
Science; 2004 Mar; 303(5663):1481-2. PubMed ID: 15001768
[No Abstract] [Full Text] [Related]
4. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
5. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
Schmitz F; Mages J; Heit A; Lang R; Wagner H
Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
[TBL] [Abstract][Full Text] [Related]
8. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
[TBL] [Abstract][Full Text] [Related]
9. Intracellular bacterial biofilm-like pods in urinary tract infections.
Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
[TBL] [Abstract][Full Text] [Related]
10. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
11. Impact of Toll-like receptor signalling on urinary tract infection.
Scherberich JE; Hartinger A
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of molecular defence mechanisms operative during urinary tract infection.
Weichhart T; Haidinger M; Hörl WH; Säemann MD
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.
Meng G; Rutz M; Schiemann M; Metzger J; Grabiec A; Schwandner R; Luppa PB; Ebel F; Busch DH; Bauer S; Wagner H; Kirschning CJ
J Clin Invest; 2004 May; 113(10):1473-81. PubMed ID: 15146245
[TBL] [Abstract][Full Text] [Related]
14. LRRC19, a novel member of the leucine-rich repeat protein family, activates NF-kappaB and induces expression of proinflammatory cytokines.
Chai L; Dai L; Che Y; Xu J; Liu G; Zhang Z; Yang R
Biochem Biophys Res Commun; 2009 Oct; 388(3):543-8. PubMed ID: 19679103
[TBL] [Abstract][Full Text] [Related]
15. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors.
Sirard JC; Bayardo M; Didierlaurent A
Eur J Immunol; 2006 Feb; 36(2):260-3. PubMed ID: 16453385
[TBL] [Abstract][Full Text] [Related]
16. Interaction of uropathogenic Escherichia coli with host uroepithelium.
Kau AL; Hunstad DA; Hultgren SJ
Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
[TBL] [Abstract][Full Text] [Related]
17. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells.
Griesbeck-Zilch B; Meyer HH; Kühn CH; Schwerin M; Wellnitz O
J Dairy Sci; 2008 Jun; 91(6):2215-24. PubMed ID: 18487644
[TBL] [Abstract][Full Text] [Related]
20. Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection.
Säemann MD; Weichhart T; Hörl WH; Zlabinger GJ
Eur J Clin Invest; 2005 Apr; 35(4):227-35. PubMed ID: 15816991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]